L. Ibanez et al., POSTPUBERTAL OUTCOME IN GIRLS DIAGNOSED OF PREMATURE PUBARCHE DURING CHILDHOOD - INCREASED FREQUENCY OF FUNCTIONAL OVARIAN HYPERANDROGENISM, The Journal of clinical endocrinology and metabolism, 76(6), 1993, pp. 1599-1603
The postpubertal outcome of a group of girls diagnosed of premature pu
barche during childhood was assessed 1) to determine the incidence of
functional ovarian hyperandrogenism (FOH) through the ovarian-steroido
genic response to the GnRH agonist leuprolide acetate, 2) to validate
leuprolide acetate stimulation in FOH diagnosis, and 3) to ascertain w
hether FOH-predictive biochemical markers exist at the diagnosis of pr
emature pubarche. Of 35 patients (age, 15.4 +/- 1.5 yr), 16 showed hir
sutism, oligomenorrhea, and elevated baseline testosterone and/or andr
ostenedione (DELTA4-A) levels. Subcutaneous administration of leuproli
de acetate (500 mug) produced similar increases in gonadotropin levels
in oligomenorrheic patients, regularly menstruating patients (n = 19)
, and controls (n = 12; age, 15.3 +/- 1.3 yr) when tested at 6 h. Of a
ll of the steroids measured, 17-hydroxyprogesterone (17-OHP) and DELTA
4-A levels 24 h postleuprolide acetate stimulation were significantly
higher in oligomenorrheic patients than in the other two groups (P < 0
.0001). No overlapping in 17-OHP responses occurred between oligomenor
rheic patients and the other groups. Baseline dehydroepiandrosterone s
ulfate and DELTA4-A levels at the diagnosis of premature pubarche corr
elated with 17-OHP values postleuprolide acetate challenge (r = 0.47;
P < 0.005 and r = 0.67; P < 0.0001, respectively). These results show
a distinct leuprolide acetate challenge response in 45% of the postpub
ertal premature pubarche girls studied, suggestive of an increased inc
idence of FOH, and support the need for continued routine postmenarche
al evaluation of this group of patients. Responses of 17-OHP to leupro
lide acetate challenge facilitate the identification of FOH patients,
establish this test as a reliable diagnostic tool in FOH diagnosis, an
d confirm the ovaries as the source of hyperandrogenemia in most patie
nts with androgen excess. Although increased 17-OHP responses after le
uprolide acetate stimulation seem to occur more frequently in girls wi
th elevated dehydroepiandrosterone sulfate and/or DELTA4-A levels at t
he diagnosis of premature pubarche, specific biochemical markers predi
ctive of FOH in this group of patients are still lacking.